Article | Published:

Tetrahydroisoquinoline Alkaloids: in vivo Metabolites of L-Dopa in Man

Abstract

Tetrahydroisoquinoline alkaloids have been unequivocally demonstrated in vivo for the first time in parkinsonian patients on L-dopa treatment. Their biosynthesis may have a profound bearing on how L-dopa acts.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Sandler, M., in Handbook of Experimental Pharmacology, Cate-cholamines 33, 845 (Springer, Berlin,1972).

  2. 2

    Whaley, W. M., and Govindachari, T. R., in Organic Reactions (edit. by Adams, R.), 6, 151 (Wiley, New York,1951).

  3. 3

    Sourkes, T. L., Nature, 229, 413 (1971).

  4. 4

    Lancet, ii, 24 (1972).

  5. 5

    Halushka, P. V., and Hoffmann, P. C., Biochem. Pharmacol., 17, 1873 (1968).

  6. 6

    Karoum, F., Cattabeni, F., Costa, E., Ruthven, C. R. J., and Sandler, M., Analyt. Biochem., 47, 550 (1972).

  7. 7

    Hammar, C.-G., Holmstedt, B., Lindgren, J. E., and Tham, R., Adv. Pharmacol. Chemother., 7, 53 (1969).

  8. 8

    Hammar, C.-G., Holmstedt, B., and Ryhage, R., Analyt. Biochem., 25, 532 (1968).

  9. 9

    Gaffney, T. E., Hammar, C.-G., Holmstedt, B., and McMahon, R. E., Analyt. Chem., 43, 307 (1971).

  10. 10

    Björklund, A., Falck, B., and Owman, C., in The Thyroid and Biogenic Amines; Methods in Investigative and Diagnostic Endocrinology, (edit. by Rall, J. E., and Kopin, I. J.), 1, 318 (North-Holland, Amsterdam, 1972).

  11. 11

    Robbins, J. H., Clin. Res., 16, 350 (1968).

  12. 12

    Robbins, J. H., Clin. Res., 16, 554 (1968).

  13. 13

    McManus, I. R., Contag, A. O., and Olson, R. E., Science, 131, 102 (1960).

  14. 14

    Krebs, H. A., and Perkins, J. R., Biochem. J., 118, 635 (1970).

  15. 15

    Blomstrand, R., Life Sci. II, 10, 575 (1971).

  16. 16

    Axelrod, J., and Daly, J., Science, 150, 892 (1965).

  17. 17

    Ciaranello, R. D., Bankers, H. J., and Barchas, J. D., Molec. Pharmacol., 8, 311 (1972).

  18. 18

    Laidlaw, P. P., J Physiol, 40, 480 (1910).

  19. 19

    Calne, D. B., Petrie, A., Rao, S., Reid, J. L., and Vakil, S. D., Brit. J. Pharmacol., 44, 162 (1972).

  20. 20

    Burn, J. H., Brit. Med. J., 1, 629 (1970).

  21. 21

    Goldberg, L. I., Pharmacol. Rev., 24, 1 (1972).

  22. 22

    Owen, D. A. L., and Marsden, C. D., Lancet, ii, 1259 (1965).

  23. 23

    Muenter, M. D., Ann. Int. Med., 75, 795 (1971).

  24. 24

    Abramsky, O., Carmon, A., and Lavy, S., J. Neurol. Sci., 14, 491 (1971).

  25. 25

    Kissel, P., Tridon, P., Masingue, M., and Andre, J. M., Nouv. Presse Méd., 1, 1943 (1972).

  26. 26

    Scheckel, C. L., Boff, W., and Pazery, L. M., Ann. NY Acad. Sci., 159, 939 (1969).

  27. 27

    Strian, F., Micheler, E., and Benkert, O., Pharmakopsychiat. Neuro-Psychopharmak., 5, 198 (1972).

  28. 28

    De long, H. H., Experimental Catatonia, (Williams and Wilkins, Baltimore, 1945).

  29. 29

    Ernst, A. M., Psychopharmacologia, 7, 391 (1965).

  30. 30

    Yaryura-Tobias, J. A., Diamond, B., and Merlis, S., Curr. Therap. Res., 12, 528 (1970).

  31. 31

    Weil-Malherbe, H., in Methods of Biochemical Analysis; Analysis of Biogenic Amines and their Related Enzymes, (edit. by Glick, D.), Suppl. vol., 119 (Interscience, New York, 1971).

  32. 32

    Lund, A., Acta Pharmacol. Toxicol., 5, 231 (1949).

  33. 33

    Crout, R. J., in Standard Methods of Clinical Chemistry,(edit. by Seligson, D.), 3, 62 (Academic Press, New York, 1961).

  34. 34

    Sandler, M., and Ruthven, C. R. J., in Chromatographic and Electrophoretic Techniques, (edit. by Smith, I.), third ed., 1, 714 (Heinemann, London, 1969).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.